Prophylactic furosemide to prevent transfusion-associated circulatory overload: a randomized controlled study in rats

[1]  喬 嶋本.  Nested Case-control Study , 1992, Definitions.

[2]  J. V. van Buul,et al.  Volume incompliance and transfusion are essential for transfusion‐associated circulatory overload: a novel animal model , 2019, Transfusion.

[3]  M. Murphy,et al.  Transfusion-Associated Circulatory Overload: A Clinical Perspective. , 2019, Transfusion medicine reviews.

[4]  R. McCarron,et al.  Blood transfusions, blood storage, and correlation with elevated pulmonary arterial pressures , 2019, Transfusion.

[5]  A. Kiss,et al.  Can furosemide prevent transfusion‐associated circulatory overload? Results of a pilot, double‐blind, randomized controlled trial , 2019, Transfusion.

[6]  J. Callum,et al.  Transfusion‐associated circulatory overload prevention: a retrospective observational study of diuretic use , 2018, Vox sanguinis.

[7]  J. Binnekade,et al.  Incidence, risk factors, and outcome of transfusion‐associated circulatory overload in a mixed intensive care unit population: a nested case‐control study , 2018, Transfusion.

[8]  I. Attaye,et al.  Transfusion-associated circulatory overload: A survey among Dutch intensive care fellows. , 2017, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[9]  W. Kuebler,et al.  Cytokine-Regulation of Na+-K+-Cl− Cotransporter 1 and Cystic Fibrosis Transmembrane Conductance Regulator—Potential Role in Pulmonary Inflammation and Edema Formation , 2017, Front. Immunol..

[10]  S. Kleinman,et al.  Incidence and clinical characteristics of transfusion‐associated circulatory overload using an active surveillance algorithm , 2017, Vox sanguinis.

[11]  J. Callum,et al.  The association of fever with transfusion‐associated circulatory overload , 2017, Vox sanguinis.

[12]  Lloyd H. Michael,et al.  The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.

[13]  A. Tejani,et al.  Loop diuretics for patients receiving blood transfusions. , 2015, The Cochrane database of systematic reviews.

[14]  J. Steingrub,et al.  Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion‐associated circulatory overload have proinflammatory aspects? , 2012, Transfusion.

[15]  D. Triulzi,et al.  Transfusion‐associated circulatory overload after plasma transfusion , 2012, Transfusion.

[16]  N. Blumberg,et al.  An association between decreased cardiopulmonary complications (TRALI and TACO) and implementation of universal leukoreduction of blood transfusions , 2010 .

[17]  N. Blumberg,et al.  An association between decreased cardiopulmonary complications (transfusion‐related acute lung injury and transfusion‐associated circulatory overload) and implementation of universal leukoreduction of blood transfusions , 2010, Transfusion.

[18]  J. McMurray,et al.  The acute vascular effects of frusemide in heart failure. , 2000, British journal of clinical pharmacology.

[19]  A. Hughes,et al.  Direct vascular effects of furosemide in humans. , 1997, Circulation.

[20]  L. Sechi,et al.  Acute effects of furosemide on blood pressure in functionally anephric, volume-expanded rats. , 1993, American journal of nephrology.

[21]  N. Nand,et al.  Furosemide supplemented blood transfusion in cases of chronic severe anemia. , 1986, Japanese heart journal.

[22]  N. Nand,et al.  Hemodynamic evaluation of blood transfusion in chronic severe anemia with special reference to speed of transfusion. , 1985, Japanese heart journal.

[23]  H. Unruh,et al.  The effect of lung edema on pulmonary vasoactivity of furosemide. , 1983, The Journal of surgical research.

[24]  J. Mohan,et al.  Haemodynamic Changes Following Blood Transfusion in Cases of Chronic Severe Anemia: Increased Safety with Simultaneous Furosemide Administration , 1983, Angiology.

[25]  L. Paalzow,et al.  Dose-dependent pharmacokinetics of furosemide in the rat. , 1982, Biopharmaceutics & drug disposition.

[26]  F. Leenen.  Diuretic and cardiovascular effects of furosemide in rats. , 1981, Canadian journal of physiology and pharmacology.

[27]  H. E. Williamson,et al.  The role of the kidney in the early nondiuretic action of furosemide to reduce elevated left atrial pressure in the hypervolemic dog. , 1977, The Journal of pharmacology and experimental therapeutics.

[28]  S. Shaughnessy,et al.  Do No Harm: Health Systems’ Duty to Promote Clinician Well-Being , 2022, American Journal of Hospital Medicine.

[29]  C. Bentzel,et al.  Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. , 1975, Prostaglandins.

[30]  J. Forrester,et al.  Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. , 1973, The New England journal of medicine.

[31]  S. C. Manchanda,et al.  Effect of Frusemide on Pulmonary Blood Volume , 1969, British medical journal.

[32]  Frusemide in acute pulmonary oedema. , 1967, Lancet.